UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Programmed death receptor-1/programmed death receptor ligand-1 blockade after transient lymphodepletion to treat myeloma

The Journal of immunology (1950), 2013-06, Vol.190 (11), p.5620-5628

2013

Volltextzugriff (PDF)

PD-1 blockade after bispecific LV20.19 CAR T modulates CAR T-cell immunophenotype without meaningful clinical response

Haematologica (Roma), 2021-10, Vol.106 (10), p.2788-2790

2021

Volltextzugriff (PDF)

Combined immune checkpoint protein blockade and low dose whole body irradiation as immunotherapy for myeloma

Journal for immunotherapy of cancer, 2015-01, Vol.3 (1), p.2-2, Article 2

2015

Volltextzugriff (PDF)

Prevention of Tumor Growth and Dissemination by In Situ Vaccination with Mitochondria‐Targeted Atovaquone

Advanced science, 2022-04, Vol.9 (12), p.e2101267-n/a

2022

Volltextzugriff (PDF)

Bispecific anti-CD20, anti-CD19 CAR T cells for relapsed B cell malignancies: a phase 1 dose escalation and expansion trial

Nature medicine, 2020-10, Vol.26 (10), p.1569-1575

2020

Volltextzugriff (PDF)

Synchronous effects of targeted mitochondrial complex I inhibitors on tumor and immune cells abrogate melanoma progression

iScience, 2021-06, Vol.24 (6), p.102653-102653, Article 102653

2021

Volltextzugriff (PDF)

Induction of activated T follicular helper cells is critical for anti-FVIII inhibitor development in hemophilia A mice

Blood advances, 2019-10, Vol.3 (20), p.3099-3110

2019

Volltextzugriff (PDF)

Mitochondria-Targeted Analogues of Metformin Exhibit Enhanced Antiproliferative and Radiosensitizing Effects in Pancreatic Cancer Cells

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (13), p.3904-3915

2016

Volltextzugriff (PDF)

Irradiation of the kidneys causes pathologic remodeling in the nontargeted heart: A role for the immune system

FASEB bioAdvances, 2020-12, Vol.2 (12), p.705-719

2020

Volltextzugriff (PDF)

Inhibition of lung tumorigenesis by a small molecule CA170 targeting the immune checkpoint protein VISTA

Communications biology, 2021-07, Vol.4 (1), p.906-11, Article 906

2021

Volltextzugriff (PDF)

The effect of tocilizumab on patient reported outcomes and inflammatory biomarkers in hematopoietic cell transplantation

Brain, behavior, & immunity. Health, 2022-08, Vol.23, p.100480, Article 100480

2022

Volltextzugriff (PDF)

Delayed neurotoxicity after axicabtagene ciloleucel therapy in relapsed refractory diffuse large B-cell lymphoma

Bone marrow transplantation (Basingstoke), 2021-03, Vol.56 (3), p.683-685

2021

Volltextzugriff (PDF)

Adoptive cell therapy using PD-1 + myeloma-reactive T cells eliminates established myeloma in mice

Journal for immunotherapy of cancer, 2017-06, Vol.5 (1), p.51-51, Article 51

2017

Volltextzugriff (PDF)

Manufacturing chimeric antigen receptor T cells from cryopreserved peripheral blood cells: time for a collect-and-freeze model?

Cytotherapy (Oxford, England), 2021-11, Vol.23 (11), p.985-990

2021

Volltextzugriff (PDF)

Translational Advances in Cancer Prevention Agent Development (TACPAD) Virtual Workshop on Immunomodulatory Agents: Report

대한암예방학회지, 2021, 26(4), , pp.309-317

2021

Volltextzugriff (PDF)

Bispecific targeting of CD20 and CD19 increases polyfunctionality of chimeric antigen receptor T-cell products in B-cell malignancies

Cytotherapy (Oxford, England), 2022-08, Vol.24 (8), p.767-773

2022

Volltextzugriff (PDF)

Tumor antigen analysis in neuroblastoma by serological interrogation of bioinformatic data

Cancer science, 2010-11, Vol.101 (11), p.2316-2324

2010

Volltextzugriff (PDF)

STING agonist inflames the pancreatic cancer immune microenvironment and reduces tumor burden in mouse models

Journal for immunotherapy of cancer, 2019-04, Vol.7 (1), p.115-115, Article 115

2019

Volltextzugriff (PDF)

Long‐term outcomes and predictors of early response, late relapse, and survival for patients treated with bispecific LV20.19 CAR T‐cells

American journal of hematology, 2022-12, Vol.97 (12), p.1580-1588

2022

Volltextzugriff (PDF)

Bone Marrow-derived CD8+ T Cells From Pediatric Leukemia Patients Express PD1 and Expand Ex Vivo Following Induction Chemotherapy

Journal of pediatric hematology/oncology, 2019-11, Vol.41 (8), p.648-652

2019

Volltextzugriff (PDF)

Intrathecal chemotherapy for management of steroid-refractory CAR T-cell–associated neurotoxicity syndrome

Blood advances, 2020-05, Vol.4 (10), p.2119-2122

2020

Volltextzugriff (PDF)

Frontline Science: PECAM‐1 (CD31) expression in naïve and memory, but not acutely activated, CD8+ T cells

Journal of leukocyte biology, 2018-11, Vol.104 (5), p.883-893

2018

Volltextzugriff (PDF)

T Cells Deficient in Diacylglycerol Kinase ζ Are Resistant to PD-1 Inhibition and Help Create Persistent Host Immunity to Leukemia

Cancer research (Chicago, Ill.), 2017-10, Vol.77 (20), p.5676-5686

2017

Volltextzugriff (PDF)

Use of Early Intrathecal Therapy to Manage High-Grade Immune Effector Cell-Associated Neurotoxicity Syndrome

JAMA oncology, 2022-05, Vol.8 (5), p.773

2022

Volltextzugriff (PDF)

STING Activated Tumor-Intrinsic Type I Interferon Signaling Promotes CXCR3 Dependent Antitumor Immunity in Pancreatic Cancer

Cellular and molecular gastroenterology and hepatology, 2021-01, Vol.12 (1), p.41-58

2021

Volltextzugriff (PDF)

1 – 25 von 183

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(141)
Mit Volltextzugriff
(164)

Publikationsform

Artikel
(160)
Buchkapitel
(20)
Bücher
(2)
Reviews
(1)

Sprache

Englisch
(183)

Erscheinungsjahr

n.n

Thema

Science & Technology
(84)
Life Sciences & Biomedicine
(77)
Animals
(49)
Mice
(43)
Immunology
(42)
Humans
(34)
Oncology
(27)
Hematology
(25)
Cell Biology
(20)
Biological And Medical Sciences
(17)
Immunotherapy
(16)
Male
(15)
Cell Line, Tumor
(14)
Female
(14)
Medical Sciences
(14)
Mice, Inbred C57bl
(14)
Cancer Vaccines - Immunology
(12)
Cd4-Positive T-Lymphocytes - Immunology
(12)
Neuroblastoma - Immunology
(12)
T Cells
(12)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Programmed death receptor-1/programmed death receptor ligand-1 blockade after transient lymphodepletion to treat myeloma

PD-1 blockade after bispecific LV20.19 CAR T modulates CAR T-cell immunophenotype without meaningful clinical response

Combined immune checkpoint protein blockade and low dose whole body irradiation as immunotherapy for myeloma

Prevention of Tumor Growth and Dissemination by In Situ Vaccination with Mitochondria‐Targeted Atovaquone

Bispecific anti-CD20, anti-CD19 CAR T cells for relapsed B cell malignancies: a phase 1 dose escalation and expansion trial

Synchronous effects of targeted mitochondrial complex I inhibitors on tumor and immune cells abrogate melanoma progression

Induction of activated T follicular helper cells is critical for anti-FVIII inhibitor development in hemophilia A mice

Mitochondria-Targeted Analogues of Metformin Exhibit Enhanced Antiproliferative and Radiosensitizing Effects in Pancreatic Cancer Cells

Irradiation of the kidneys causes pathologic remodeling in the nontargeted heart: A role for the immune system

Inhibition of lung tumorigenesis by a small molecule CA170 targeting the immune checkpoint protein VISTA

The effect of tocilizumab on patient reported outcomes and inflammatory biomarkers in hematopoietic cell transplantation

Delayed neurotoxicity after axicabtagene ciloleucel therapy in relapsed refractory diffuse large B-cell lymphoma

Adoptive cell therapy using PD-1 + myeloma-reactive T cells eliminates established myeloma in mice

Manufacturing chimeric antigen receptor T cells from cryopreserved peripheral blood cells: time for a collect-and-freeze model?

Translational Advances in Cancer Prevention Agent Development (TACPAD) Virtual Workshop on Immunomodulatory Agents: Report

Bispecific targeting of CD20 and CD19 increases polyfunctionality of chimeric antigen receptor T-cell products in B-cell malignancies

Tumor antigen analysis in neuroblastoma by serological interrogation of bioinformatic data

STING agonist inflames the pancreatic cancer immune microenvironment and reduces tumor burden in mouse models

Long‐term outcomes and predictors of early response, late relapse, and survival for patients treated with bispecific LV20.19 CAR T‐cells

Bone Marrow-derived CD8+ T Cells From Pediatric Leukemia Patients Express PD1 and Expand Ex Vivo Following Induction Chemotherapy

Intrathecal chemotherapy for management of steroid-refractory CAR T-cell–associated neurotoxicity syndrome

Frontline Science: PECAM‐1 (CD31) expression in naïve and memory, but not acutely activated, CD8+ T cells

T Cells Deficient in Diacylglycerol Kinase ζ Are Resistant to PD-1 Inhibition and Help Create Persistent Host Immunity to Leukemia

Use of Early Intrathecal Therapy to Manage High-Grade Immune Effector Cell-Associated Neurotoxicity Syndrome

STING Activated Tumor-Intrinsic Type I Interferon Signaling Promotes CXCR3 Dependent Antitumor Immunity in Pancreatic Cancer

Suchergebnisse filtern